Incyte Corp at RBC Capital Markets Global Healthcare Conference Transcript
All right. Good morning, everyone. I'm Brian Abrahams, one of the senior biotech analysts at RBC Capital Markets, and thanks for joining us. Really pleased to have our next featured company Incyte, represented by their Chief Medical Officer, Steven Stein; and their Chief Financial Officer, Christiana Stamoulis. So thanks again for being here, and it's great to see you guys in person.
Thank you for having us.
Questions & Answers
Great. So I know there's a lot going on at Incyte, a lot to talk about, but we probably get the most questions these days on the OPZELURA launch. So maybe we can start with that. And maybe if you could just start broadly on how the launch is going. Where you're seeing the drug fitting into the atopic derm treatment paradigm, how docs are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
